Literature DB >> 34252324

Missed Opportunities for Human Papillomavirus Vaccination by Parental Nativity, Minnesota, 2015-2018.

Emily A Groene1, Keith J Horvath1, Nicholas Yared1, Inari Mohammed1, Miriam Muscoplat2, Sydney Kuramoto2, Tyler Richter1, Shalini Kulasingam1.   

Abstract

OBJECTIVES: Human papillomavirus (HPV) vaccination coverage in the United States is far below coverage for other routine adolescent vaccines. We examined whether missed opportunities for HPV vaccination among adolescents differ by parental nativity (country of origin) in Minnesota.
METHODS: We retrospectively analyzed birth record and immunization information data for adolescents in Minnesota born during 2004-2007 using data from January 1, 2015, through December 31, 2018. Using logistic regression, we assessed the association between parental nativity and missed opportunities for HPV vaccine initiation, or receipt of other vaccines without receipt of the HPV vaccine. We adjusted for parent/child demographic and vaccination characteristics. We defined nativity as the number of non-US-born parents and maternal region of birth.
RESULTS: Adolescents with mothers born in Eastern Europe (adjusted odds ratio [aOR] = 2.33; 95% CI, 2.01-2.73) and Africa (aOR = 1.36; 95% CI, 1.28-1.43) had greater adjusted odds of missed opportunities for HPV vaccination than adolescents with US-born mothers. However, adolescents with mothers from Latin America and the Caribbean had lower odds of missed opportunities than adolescents with US-born mothers (aOR = 0.61; 95% CI, 0.58-0.65). Adolescents with 1 or 2 non-US-born parents had lower odds of missed opportunities for HPV vaccination than adolescents with 2 US-born parents (1 parent: aOR = 0.92; 95% CI, 0.88-0.96; 2 parents: aOR = 0.90; 95% CI, 0.87-0.94).
CONCLUSIONS: Future studies should evaluate outreach to groups with HPV vaccination disparities and identify other drivers of missed opportunities among adolescents with US-born parents, such as multiparity.

Entities:  

Keywords:  adolescents; human papillomavirus; nativity; vaccination

Mesh:

Substances:

Year:  2021        PMID: 34252324      PMCID: PMC9379833          DOI: 10.1177/00333549211027244

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  38 in total

1.  Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010.

Authors:  Jacqueline M Hirth; Mahbubur Rahman; Jennifer S Smith; Abbey B Berenson
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  A Population-Based Study of Sociodemographic and Geographic Variation in HPV Vaccination.

Authors:  Lila J Finney Rutten; Patrick M Wilson; Debra J Jacobson; Amenah A Agunwamba; Carmen Radecki Breitkopf; Robert M Jacobson; Jennifer L St Sauver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-02-14       Impact factor: 4.254

3.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Elissa Meites; Allison Kempe; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-16       Impact factor: 17.586

4.  Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008.

Authors:  Stephanie A S Staras; Susan T Vadaparampil; Laura T Haderxhanaj; Elizabeth A Shenkman
Journal:  J Adolesc Health       Date:  2010-10       Impact factor: 5.012

5.  Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Authors:  Elmar A Joura; Kevin A Ault; F Xavier Bosch; Darron Brown; Jack Cuzick; Daron Ferris; Suzanne M Garland; Anna R Giuliano; Mauricio Hernandez-Avila; Warner Huh; Ole-Erik Iversen; Susanne K Kjaer; Joaquin Luna; Dianne Miller; Joseph Monsonego; Nubia Munoz; Evan Myers; Jorma Paavonen; Punnee Pitisuttithum; Marc Steben; Cosette M Wheeler; Gonzalo Perez; Alfred Saah; Alain Luxembourg; Heather L Sings; Christine Velicer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10       Impact factor: 4.254

6.  Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010.

Authors:  Mahbubur Rahman; Tabassum H Laz; Abbey B Berenson
Journal:  Vaccine       Date:  2013-09-23       Impact factor: 3.641

7.  Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.

Authors:  Laia Bruni; Mireia Diaz; Leslie Barrionuevo-Rosas; Rolando Herrero; Freddie Bray; F Xavier Bosch; Silvia de Sanjosé; Xavier Castellsagué
Journal:  Lancet Glob Health       Date:  2016-07       Impact factor: 26.763

8.  Geographic Factors and Human Papillomavirus (HPV) Vaccination Initiation among Adolescent Girls in the United States.

Authors:  Kevin A Henry; Antoinette M Stroup; Echo L Warner; Deanna Kepka
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-14       Impact factor: 4.254

9.  Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study.

Authors:  Hannah C Moore; Parveen Fathima; Heather F Gidding; Nicholas de Klerk; Bette Liu; Vicky Sheppeard; Paul V Effler; Thomas L Snelling; Peter McIntyre; Christopher C Blyth
Journal:  Vaccine       Date:  2018-05-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.